Home>Media>Newsroom – 2016 Media Newsroom - 2016 Glenmark Pharmaceuticals receives ANDA approval for Tretinoin Capsules, 10 mg 27 DEC 2016 | READ MORE Glenmark Unveils its Strategic Blueprint for Transition into an Innovation‐Led Global Pharmaceutical Organization in the Next Decade 19 DEC 2016 | READ MORE Glenmark Launches First and Only Generic Version of Zetia® in the United States 12 DEC 2016 | READ MORE Glenmark announces Pre-Clinical Data Results for experimental GBR 1302-Beat Technology 4 NOV 2016 | READ MORE Glenmark announces Strategic Development and Global Licensing Agreement with Particle Sciences 19 SEP 2016 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Diclofenac Sodium Gel, 3% 14 SEP 2016 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Lidocaine Ointment USP, 5% 12 SEP 2016 | READ MORE Glenmark announces the Discovery and Initiation of IND‐enabling studies of a novel Bispecific Monoclonal Antibody targeting EGFR 6 SEP 2016 | READ MORE Glenmark’s consolidated revenue increased by 18% for Q1 FY 2016 – 17 12 AUG 2016 | READ MORE ANDA approval for Potassium Chloride Extended-Release Tablets 27 JUL 2016 | READ MORE ANDA approval of Rosuvastatin Calcium Tablets 20 JUL 2016 | READ MORE Glenmark Pharmaceuticals receives tentative ANDA approval for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg 24 JUN 2016 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/1 mg per gram 24 JUN 2016 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Rufinamide Tablets USP, 200 mg and 400 mg 19 MAY 2016 | READ MORE Glenmark’s Consolidated Revenue for Q4 FY 2015 – 16 was at Rs. 23066.76 Mn recording an increase of 29.89% 12 MAY 2016 | READ MORE Glenmark Pharmaceuticals receives tentative ANDA approval for Adapalene and Benzoyl Peroxide Gel 29 APR 2016 | READ MORE Glenmark Pharmaceuticals receives tentative ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets 26 APR 2016 | READ MORE Glenmark Pharmaceuticals receives another two ANDA approvals from the U.S. FDA 28 MAR 2016 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Bendamustine Hydrochloride for Injection 28 MAR 2016 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Raloxifene Hydrochloride Tablets. 23 MAR 2016 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Frovatriptan Succinate Tablets 18 MAR 2016 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Frovatriptan Succinate Tablets 14 MAR 2016 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Norgestimate and Ethinyl Estradiol Tablets 24 FEB 2016 | READ MORE Glenmark Pharmaceuticals receives tentative ANDA approval for Azelaic Acid Gel 17 FEB 2016 | READ MORE Glenmark’s Consolidated Net Profit increases by 48.38% to Rs. 1703 Mn in Q3 FY 15-16 28 JAN 2016 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Capsules/ 21 JAN 2016 | READ MORE Glenmark Pharmaceuticals receives ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets. 21 JAN 2016 | READ MORE Glenmark announces the Discovery and Initiation of IND‐enabling studies of a novel bi‐specific monoclonal antibody targeting CD38. 8 JAN 2016 | READ MORE Glenmark Pharmaceuticals Inc., USA receives tentative ANDA approval for Dronedarone Tablets 6 JAN 2016 | READ MORE Year – 2024 Year – 2023 Year – 2022 Year – 2021 Year – 2020 Year – 2019 Year – 2018 Year – 2017 Year – 2016 Year – 2015
